Tanvi Joshi
Obstetrics & Gynecology · Cincinnati, OHNPI 1083107924
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $918 and has fallen 75.9% since, to $221 in 2025.
Across 107 payments — averaging $20.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$340
- AstraZeneca$328
- Regeneron Healthcare Solutions, Inc.$302
- Johnson & Johnson$154
- GSK$134
- Merck$131
- plus $829 from 19 others
What the payments were for
- Food & beverage$2,219100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 20 | $340 |
| AstraZeneca | 16 | $328 |
| Regeneron Healthcare Solutions, Inc. | 13 | $302 |
| Johnson & Johnson | 9 | $154 |
| GSK | 5 | $134 |
| Merck | 6 | $131 |
| Incyte Corporation | 5 | $120 |
| Novartis | 4 | $82 |
| AbbVie | 3 | $76 |
| Hologic Sales And Service, LLC | 1 | $69 |
| Pharmaessentia USA Corporation | 3 | $61 |
| Stemline Therapeutics Inc. | 3 | $54 |
| Pfizer | 2 | $45 |
| Tersera Therapeutics LLC | 2 | $40 |
| Sanofi | 2 | $38 |
| Baxter Healthcare | 2 | $36 |
| Genentech USA, Inc. | 2 | $33 |
| Coopersurgical, Inc. | 1 | $32 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Fennec Pharmaceuticals, Inc. | 1 | $29 |
| Dendreon Pharmaceuticals LLC | 1 | $20 |
| ADC Therapeutics America, Inc. | 1 | $19 |
| Octapharma USA, Inc. | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$2,219 in reported general payments places this provider in the 75th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Megestrol Acetate | 12 | $322 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $107 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Cincinnati
- David SchwartzCincinnati$169K
- Gerard ReillyCincinnati$74K
- Michael KarramCincinnati$47K
- Sunbal JavaidCincinnati$32K
- James SosnowskiCincinnati$31K
- Gretchen FermannCincinnati$31K
- Rocco RossiCincinnati$18K
- Meredith PensakCincinnati$14K
- David DhanrajCincinnati$12K
- David SheynCincinnati$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.